Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Monograph Eligibility To Include U.S. Rx-Only Drugs With Foreign OTC Data

This article was originally published in The Tan Sheet

Executive Summary

A drug marketed OTC in foreign countries but limited to Rx use in the U.S. could be considered for eligibility in the OTC monograph system under FDA's final rule on "material time, material extent" criteria, published in the Federal Register Jan. 23
Advertisement

Related Content

FDA Seeks Data On Triclosan, Considers OTC Acne Monograph Inclusion
FDA Seeks Data On Triclosan, Considers OTC Acne Monograph Inclusion
FDA Seeks Data On Triclosan, Considers OTC Acne Monograph Inclusion
Triclosan Antigingivitis/Antiplaque Monograph Status Sought By Ciba
Triclosan Antigingivitis/Antiplaque Monograph Status Sought By Ciba
Additional Valerian Safety Data Needed To Gain OTC Status, FDA Says
Additional Valerian Safety Data Needed To Gain OTC Status, FDA Says
“Time & Extent” Botanical Candidates To Lead Off With Ginger, Valerian?
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs
OTC “Time & Extent” Requirements Reduced For Extensively Marketed Drugs

Topics

Advertisement
UsernamePublicRestriction

Register

PS093547

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel